Detalhe da pesquisa
1.
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.
Hepatol Res
; 50(8): 966-977, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32562334
2.
[Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors].
Rinsho Ketsueki
; 55(1): 130-2, 2014 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-24492046
3.
Phase II study of combined treatment with irinotecan and S-1 (IRIS) in patients with inoperable or recurrent advanced colorectal cancer (HGCSG0302).
Oncology
; 80(1-2): 70-5, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21659785
4.
Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting.
JGH Open
; 4(1): 54-60, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055698
5.
Large solid-pseudopapillary neoplasm of the pancreas with aberrant protein expression and mutation of ß-catenin: a case report and literature review of the distribution of ß-catenin mutation.
Intern Med
; 52(18): 2051-6, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24042511
6.
Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: Zoonotic food-borne transmission of hepatitis E virus and public health concerns.
Hepatol Res
; 42(9): 870-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22568494
7.
Endoscopic follow-up of 3 cases with gastrointestinal tract involvement of mantle cell lymphoma.
Intern Med
; 49(3): 231-5, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20118601